HHS Secretary Azar says that he and President Trump are working on policy proposals that will address the high cost of prescription drugs. The question is whether they can do so without harming biomedical innovation.
HHS Secretary Azar says that he and President Trump are working on policy proposals that will address the high cost of prescription drugs. The question is whether they can do so without harming biomedical innovation.